1381868-48-9

Basic information

• Product Name: C₄₈H₆₁N₇O₁₀S
• Synonyms: C₄₈H₆₁N₇O₁₀S
• CAS NO: 1381868-48-9
• Molecular Weight: 928.119
• Mol File: 1381868-48-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: C₄₈H₆₁N₇O₁₀S(CAS DataBase Reference)
• NIST Chemistry Reference: C₄₈H₆₁N₇O₁₀S(1381868-48-9)
• EPA Substance Registry System: C₄₈H₆₁N₇O₁₀S(1381868-48-9)

Safety Data

• Hazardous Substances Data: 1381868-48-9(Hazardous Substances Data)

Upstream product

• 1381868-47-8 Fmoc-Gln(Trt)-Ala-OBzl ester 
• 102185-38-6 Nα-(t-butyloxycarbonyl)-Nω-(4-methoxy-2,3,6-trimethylbenzenesulphonyl)-L-arginine 

Downstream Products

• 1381868-49-0 tert-butyl N-[1-({1-[(1-{[1-(1,3-benzothiazol-2-yl)-1-hydroxy-5-{3-[(4-methoxy-2,3,6trimethylbenzene)sulfonyl]carbamimidamido}penta-2-yl]carbamoyl}ethyl)carbamoyl]-3-[(triphenylmethyl)carbamoyl]propyl}carbamoyl)-4-{1-[(4-methoxy-2,3,6-trimethylbenzene)sulfonyl]carbamimidamido}butyl]carbamate 

Relevant articles and documents

MATRIPTASE INHIBITORS AND USES THEREOF AGAINST ORTHOMYXOVIRIDAE INFECTIONS

The present invention provides matriptase inhibitors and compositions for treating and preventing orthomyxovirus infections such as flu infections. The present invention also provides novel compounds, compositions, methods of use, uses and kits thereof for inhibiting matriptase. Such compounds are useful for treating and preventing orthomyxovirus infections, such as flu infections, and for inhibiting tumor growth, progression and/or metastasis.